Spark Therapeutics Profile

USD 4.55  5.05%

Exercise or conversion by La Barge Joseph of 3000 shares of Spark Therapeutics subject to Rule 16b-3

Spark Therapeutics insider trading alert for exercise of common stock by La Barge Joseph, General Counsel and Head of Business Administration, on June 19, 2018. This event was filed by Spark Therapeutics Inc with SEC on 2016-12-16. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Spark Therapeutics Summary

Spark Therapeutics (ONCE) is traded on NASDAQ in USA. It is located in PENNSYLVANIA, U.S.A and employs 315 people. Spark Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 3.31 B. Spark Therapeutics conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 37.39 M outstanding shares of which 5.28 M shares are now shorted by private and institutional investors with about 9.09 trading days to cover. N/A currently holds about 587.55 M in cash with (68.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.72.
Check Spark Therapeutics Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 85.53HorizonTargetOdds Above 85.53
89.33%30 days 85.53 10.56%
Based on normal probability distribution, the odds of Spark Therapeutics to move above current price in 30 days from now is about 10.56% (This Spark Therapeutics probability density function shows the probability of Spark Therapeutics Stock to fall within a particular range of prices over 30 days) .

Top Holders

Selected Spark Therapeutics Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Spark Therapeutics Against Markets